Likewise, astrocyte-derived BDNF administration reduced infarct damage after FCI (Schäbitz et al., 2000), and conditional BDNF delivery from astrocytes has also been shown to rescue memory defects, spine density and synaptic function in a mouse model of AD (de Pins et al., 2019). This evidence concerns the gene BDNF and Alzheimer disease.